Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Suparna, Chatterjee"'
Autor:
Julia Lynn Parra, Suparna Chatterjee
Publikováno v:
Education Sciences, Vol 14, Iss 1, p 68 (2024)
Prior to and during the pandemic, social media platforms such as Twitter and Facebook emerged as dynamic online spaces for diverse communities facilitating engagement and learning. The authors of this article have explored the use of social media wit
Externí odkaz:
https://doaj.org/article/98e2af31b67342e1aac9950eac448b73
Autor:
Suparna Chatterjee, Avijit Hazra, Raja Chakraverty, Nusrat Shafiq, Ashish Pathak, Niyati Trivedi, Balakrishnan Sadasivam, Ashish Kumar Kakkar, Ratinder Jhaj, Rajni Kaul, Nilima Kshirsagar
Publikováno v:
Perspectives in Clinical Research, Vol 13, Iss 2, Pp 99-105 (2022)
Purpose: This multicentric questionnaire-based study was undertaken to address the lack of systematic background data on the knowledge, attitudes, and practices among Indian physicians related to antimicrobial use and resistance. Materials and Method
Externí odkaz:
https://doaj.org/article/554b725f4a5e4fe7a3e4e5e4e16f2f2e
Autor:
Kaushik Mukhopadhyay, Soumita De, Sunanda Kundu, Parasar Ghosh, Suparna Chatterjee, Mitali Chatterjee
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 10, Iss 5, Pp 1981-1986 (2021)
Objectives: One of the most prevalent autoimmune disease globally, rheumatoid arthritis (RA) is caused by interplay of multiple inflammatory mediators in specific joints. Altered redox balance is one of the key factors in pathophysiology of RA. This
Externí odkaz:
https://doaj.org/article/14e9af00399b4b678a6b4741803526c8
Autor:
Saikat K Dalui, Raja Chakraverty, Nafisha Yasmin, Smita Pattanaik, Kaushik Pandit, Suparna Chatterjee
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 25, Iss 4, Pp 283-292 (2021)
Objectives: This meta-analysis of randomized clinical trials (RCT) intends to evaluate the efficacy of DPP4 Inhibitors (DPP4I) compared with placebo, other antidiabetics (or DPP4I) on renal outcomes, adverse events (AEs), and all-cause mortality. Met
Externí odkaz:
https://doaj.org/article/8a1996e4ce1449fd9a171605ed163f03
Publikováno v:
Perspectives in Clinical Research, Vol 11, Iss 2, Pp 75-80 (2020)
Aim: Poisoning is a preventable cause of morbidity and mortality in India. We undertook a prospective observational study to estimate the incidence, nature, severity and treatment outcome trends of acute poisoning in a tertiary care hospital in easte
Externí odkaz:
https://doaj.org/article/16889aa60b9a4901a8abbba0405deac5
Publikováno v:
Perspectives in Clinical Research, Vol 10, Iss 4, Pp 148-154 (2019)
India recently updated its guidelines on stem cell research (SCR), the National Guidelines for Stem Cell Research 2017. It was drafted under a collaborative effort from the Indian Council of Medical Research and Department of Biotechnology. The new g
Externí odkaz:
https://doaj.org/article/4201948a43ed4b8fa7436698d3489c18
Autor:
Jaya Ranjalkar, Ratinder Jhaj, Sujith J Chandy, Heber R Bright, Preeta K Chugh, Chakra D Tripathi, Dinesh K Badyal, Sadasivam Balakrishnan, Bikash Medhi, Sandhya K Kamat, Raakhi Tripathi, Harihar Dikshit, Sukalyan S Roy, Suparna Chatterjee, Manjari Bhattacharjee, Niyati Trivedi, Chetna Desai, Pooja Gupta, Atanu Roy, Ramasamy Raveendran, Jayanthi Mathaiyan, Sandeep Kaushal, Samriti Jain, Rajni Kaul, Nilima A Kshirsagar
Publikováno v:
Journal of The Association of Physicians of India. 71:30-36
Aim: Irrational use of medicines is a global problem. In India, one contributing factor is the availability of a large number of fixed-dose combinations (FDCs). To improve rational use and to strengthen policies, it is important to assess the usage p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af0a624fc35816e668b4f0832e21139f
https://doi.org/10.5005/japi-11001-0175
https://doi.org/10.5005/japi-11001-0175
Publikováno v:
Al Ameen Journal of Medical Sciences, Vol 11, Iss 03, Pp 191-198 (2018)
Background: HIV infection has a chronic course and long-term involvement associated with social stigma in India leading to serious psychological problems manifesting as depression, loss of insight, agitation, insomnia which are remain undiagnosed and
Externí odkaz:
https://doaj.org/article/c516b6b3df264958b7a89000ee6abde6
Publikováno v:
Indian Journal of Rheumatology, Vol 13, Iss 1, Pp 51-55 (2018)
India has the potential to contribute meaningfully to global clinical drug development. A critical enabler to achieve this potential is a balanced, predictable, and scientifically robust regulation involving clinical studies. In the past few years, t
Externí odkaz:
https://doaj.org/article/df2244f18a73463bbb9b3734468a52a2
Autor:
Arpita Ray Chaudhury, Thumu Venkataramana Reddy, Smita Subhash Divyaveer, Krishna Patil, Mahesh Bennikal, Kanailal Karmakar, Suparna Chatterjee, Sanjay Dasgupta, Dipankar Sircar, Rajendra Pandey
Publikováno v:
Kidney International Reports, Vol 2, Iss 6, Pp 1169-1175 (2017)
Screening school children for urinary abnormalities is an inexpensive task but is not commonly undertaken in India. Although debated in western countries, its utility in early diagnosis of kidney disorders has been proved by studies from Asia. We exa
Externí odkaz:
https://doaj.org/article/5b01235f75ef463585c5d23ac382d069